...
首页> 外文期刊>Arquivos de Gastroenterologia >Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors
【24h】

Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors

机译:大肠腺癌中p53,bcl-2和Ki-67的免疫组织化学表达分析及其与预后的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

CONTEXT: Search of tumors markers that allow treatment with higher survival rates, and indicate the response to treatment and recurrence of cancer OBJECTIVE: To analyze the immunoexpression of the proteins p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and correlate them with the clinical-pathological prognostic factors. METHOD: Tissue microarray paraffin blocks were made from colorectal adenocarcinoma tissue resected from 82 patients who had undergone surgery but not chemotherapy or radiotherapy, at "Hospital S?o Paulo", S?o Paulo, SP, Brazil, between 2002 and 2005. Thin sections (4 μm) were subjected to immunohistochemical reactions, and immunoexpression staining scores were obtained. The scores were correlated with the degree of cell differentiation, staging, disease-free interval, recurrence, survival and specific mortality. The study variables were analyzed using the chi-square and Kaplan-Meier tests to investigate associations with the markers. The significance of the differences between the curves of the disease-free interval and survival was analyzed using the Logrank and Wilcoxon tests. RESULTS: The immunohistochemical expression of p53 was positive in 70 tumors (85.4%) and negative in 12 (14.6%). The expression of bcl-2 was positive in 26 (31.7%) and negative in 56 (68.3%). The expression of Ki-67 was positive in 62 (75.6%) and negative in 20 (24.4%). There was no statistically significant correlation between the expressions of these markers separately or in conjunction, in relation to the degree of cell differentiation, staging, disease-free interval, survival and specific mortality. In relation to recurrence, there was a statistically significant correlation with positive expression of Ki-67 (P = 0.035). CONCLUSION: The immunohistochemical expression of Ki-67 in colorectal cancer is associated with recurrence of this disease.
机译:背景:寻找可提高生存率并指示对治疗和癌症复发反应的肿瘤标志物目的:分析大肠腺癌中p53,bcl-2和Ki-67蛋白的免疫表达并将其与大肠腺癌相关临床病理预后因素。方法:组织微阵列石蜡块是从2002年至2005年在巴西圣保罗的“医院圣保罗”的82例接受手术但未接受化学疗法或放射疗法的患者切除的大肠腺癌组织制成的。切片(4μm)进行免疫组织化学反应,并获得免疫表达染色分数。得分与细胞分化程度,分期,无病间隔,复发,存活率和比死亡率相关。使用卡方检验和Kaplan-Meier检验分析研究变量,以研究与标记的关联。使用Logrank和Wilcoxon检验分析了无病间隔曲线与生存曲线之间差异的显着性。结果:p53的免疫组织化学表达在70个肿瘤中为阳性(85.4%),在12个肿瘤中为阴性(14.6%)。 bcl-2表达阳性的有26例(31.7%),阴性的有56例(68.3%)。 Ki-67的阳性表达为62(75.6%),阴性为20(24.4%)。这些标志物的表达在单独或联合表达之间在细胞分化程度,分期,无病间隔,存活率和比死亡率方面无统计学意义的相关性。关于复发,与Ki-67的阳性表达有统计学意义的相关性(P = 0.035)。结论:Ki-67在大肠癌中的免疫组织化学表达与该病的复发有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号